ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 72 filers reported holding ALBIREO PHARMA INC in Q1 2020. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $72,048 | -100.0% | 3,334 | -75.9% | 0.00% | – |
| Q3 2022 | $267,942,000 | +107.5% | 13,840 | +112.9% | 0.00% | – |
| Q2 2022 | $129,130,000 | +23.5% | 6,502 | +85.5% | 0.00% | – |
| Q1 2022 | $104,554,000 | -19.8% | 3,505 | -37.4% | 0.00% | – |
| Q4 2021 | $130,447,000 | -39.7% | 5,601 | -19.2% | 0.00% | – |
| Q3 2021 | $216,154,000 | +20.8% | 6,928 | +36.2% | 0.00% | – |
| Q2 2021 | $178,890,000 | -46.0% | 5,085 | -45.9% | 0.00% | – |
| Q1 2021 | $331,068,000 | +293.3% | 9,392 | +318.5% | 0.00% | – |
| Q4 2020 | $84,172,000 | -26.7% | 2,244 | -34.8% | 0.00% | – |
| Q3 2020 | $114,793,000 | +255.2% | 3,440 | +182.0% | 0.00% | – |
| Q2 2020 | $32,318,000 | -56.3% | 1,220 | -73.0% | 0.00% | – |
| Q1 2020 | $73,878,000 | +92.6% | 4,513 | +199.1% | 0.00% | – |
| Q4 2019 | $38,359,000 | +25.1% | 1,509 | -1.6% | 0.00% | – |
| Q3 2019 | $30,660,000 | -7.2% | 1,533 | +49.6% | 0.00% | – |
| Q2 2019 | $33,046,000 | -45.9% | 1,025 | -46.0% | 0.00% | – |
| Q1 2019 | $61,102,000 | +1145.5% | 1,897 | +848.5% | 0.00% | – |
| Q4 2018 | $4,906,000 | -50.1% | 200 | -32.9% | 0.00% | – |
| Q3 2018 | $9,822,000 | -7.8% | 298 | -0.7% | 0.00% | – |
| Q2 2018 | $10,650,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 174,791 | $6,556,000 | 3.03% |
| Sio Capital Management, LLC | 354,210 | $13,286,000 | 2.72% |
| Birchview Capital, LP | 92,000 | $3,451,000 | 1.99% |
| Chicago Capital, LLC | 618,263 | $23,191,000 | 1.04% |
| Perceptive Advisors | 2,360,139 | $88,529,000 | 0.95% |
| Endurant Capital Management LP | 42,292 | $1,586,000 | 0.57% |
| Artal Group S.A. | 700,000 | $26,257,000 | 0.56% |
| Cormorant Asset Management, LP | 500,000 | $18,755,000 | 0.45% |
| Samsara BioCapital, LLC | 100,000 | $3,751,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 257,372 | $9,654,000 | 0.34% |